Frequency of primary resistance to antiretroviral drugs and genetic variability of HIV-1 among infected pregnant women recently diagnosed in Luanda-Angola

AIDS Research and Human Retroviruses

Volumn 26, Issue 12, 2010, Pages 1313-1316

  Castelbranco, Emingarda Patrícia André Félix ^a   Da Silva Souza, Edvaldo ^b   Cavalcanti, Ana Maria Salustiano ^c   Martins, Angélica Nascimento ^d   De Alencar, Luiz Claúdio Arraes ^b   Tanuri, Amilcar ^d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Institute of Integrated Medicine Prof Fernando Figueira Recife   (Brazil)

^c Central Public Health Laboratory for the State of Pernambuco (LACEN/PE)   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CD4 ANTIGEN; DIDANOSINE; EMTRICITABINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; LAMIVUDINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; POL PROTEIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; VIRUS RNA; ZIDOVUDINE;

ADULT; ANGOLA; ANTIBODY DETECTION; ANTIVIRAL RESISTANCE; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; STRUCTURAL GENE; VIRUS LOAD; VIRUS MUTATION; VIRUS TYPING;

ADOLESCENT; ADULT; ANGOLA; ANTI-RETROVIRAL AGENTS; CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; FEMALE; GENETIC VARIATION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; YOUNG ADULT;

EID: 78650277017     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0111     Document Type: Article

References (16)

1. UNAIDS. 2008 UNAIDS Annual Report Available at http://data.unaids.org/ pub/Report/2009/jc1736-2008-annual-report-en.pdf. Last accessed March/April 2010.
2. http://apps.who.int/globalatlas/predefinedReports/EFS2008/short/ EFSCountryProfiles2008-AO.pdf. Last accessed March/April 2010
3. Ministry of Health-Republic of Angola, National Institute of Fighting against AIDS-Surveillance study of HIV, Hepatitis B and Syphilis in pregnant women on prenatal consultation in Angola, 2006.
4. Ministry of Health-Republic of Angola, Guidelines for anti-retroviral treatment in Angola. 2005.
5. Garrido C, Zahonero N, Fernándes D, et al.: Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on anti-retroviral therapy in Angola. J Antimicrob Chemother 2008; 61:694-698
6. Guidelines for the Prevention of Mother to Child Trans-mission of HIV. National AIDS Control Organization. Available at: http://www.nacoonline.org/ guidelines/guideline-9.pdf. Last accessed March/April 2010.
7. Ministry of Health-Republic of Angola, National Institute of the fight against AIDS: Guidelines for the Prevention of HIV Transmission in Angola, 2005.
8. Little SJ, Holte S, Routy JP, et al.: Antiretroviral-drug resis-tance among patients recently infected with HIV. N Engl J Med 2002;347:385-394.
9. Novak RM, Chen L, MacArthur RD, et al.: Prevalence of antiretroviral drug mutations in chronically HIV-infected, treatment-nä?ve patients: Implications for routine resistance screening before initiation of antiretroviral therapy. Clin Infect Dis 2005;40:468-474.
10. Bennett DE, Camacho RJ, Otelea D, et al.: Drug resis-tance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One. 2009;4: e4724.
11. Alcantara LC, Cassol S, Libin P, et al.: A standardized framework for accurate, high-throughput genotyping of re-combinant and non-recombinant viral sequences. Nucleic Acids Res 2009;37:W634-642.
12. de Oliveira T, Deforche K, Cassol S, et al.: An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinfomatics 2005;21:3797-3800.
13. Bártolo I, Rocha C, Bartolomeu J, et al.: Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected Individuals in Angola: Evidence for low level of transmitted drug resistance. Antimicrob Agents Chemother 2009;53:3156-3158.
14. Guimarães ML, Vicente AC, Otsuki K, et al.: Close phylo-genetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates. Retrovirology 2009;22;6:39.
15. Bártolo I, Rocha C, Bartolomeu J, et al.: Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: New insights into the origins of the AIDS pandemic Infect Genet Evol 2009;9:672-682.
16. Bártolo I, Epalanga M, Bartolomeu J, et al.: High genetic diversity of human immunodeficiency virus type 1 in An-gola. AIDS Res Hum Retroviruses 2005;21:306-310.